Skip to content
Search

Latest Stories

Pharmacy contractors can start claiming extra Covid-19 costs

The community pharmacy contractors now can start claiming their extra costs incurred due to the Covid-19 pandemic, as per an update posted by Pharmaceutical Services Negotiating Committee (PSNC).

The six-week period for claiming the costs began from Monday (July 5).


The move is a part of a deal reached between the PSNC and the government in June-end.

Last week, PSNC chief executive Simon Dukes also asked community pharmacy contractors in England to claim a range of costs incurred during the coronavirus pandemic.

As per the deal, contractors can get reimbursement for specific categories of Covid related costs incurred during March 1, 2020 and March 31, 2021 for the delivery of NHS pharmaceutical services.

All claims must be submitted between July 5 and August 15 using an agreed claim form provided by the NHS Business Services Authority (NHSBSA). The payments will be made on October 1.

While submitting claims, contractors need to set out their costs according to the categories suggested by the Department of Health and Social Care (DHSC), and indicate evidence for the same.

The categories include additional staff costs due to Covid-19, IT and communication costs to support remote working and virtual patient contact, expenditure on notified closures for infection control purposes and making the premises secure.

Contractors are advised to think carefully when making their claims as DHSC has not set out detailed evidence requirements, but may ask for it on a later stage.

Besides, owner of more than one pharmacy can submit one claim for all the premises.

To help contractors in making their claims, PSNC will issue a series of guidelines. The first of these was published on Monday (Jul 5).

More For You

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard, who is set to step down as NHS England chief in April, has been appointed as the next chief executive of Guy’s and St Thomas’ NHS Foundation Trust.

Pritchard previously led the Trust from October 2015 to August 2019 before moving to NHS England, where she later became its first female chief executive in August 2021.

Keep ReadingShow less
Confirm Pharmacy First Funding beyond April- Helen Morgan MP urges health secretary

North Shropshire MP Helen Morgan

Helen Morgan MP calls on Wes Streeting to clarify Pharmacy First’s future

Liberal Democrat health and care spokesperson Helen Morgan has urged the government to provide clarity on the future of Pharmacy First and confirm continued funding beyond April.

In a letter to health secretary Wes Streeting, the North Shropshire MP expressed deep concern over the uncertainty surrounding the initiative, which plays a crucial role in shifting healthcare services into communities.

Keep ReadingShow less
NHS England restructures leadership with new executive team

Except for the deputy chief executive officer, all team members will assume their roles on 1 April 2025.

Getty Images

NHS England announces new executive team to lead transformation

Sir James Mackey will be leading NHS England’s transition into the Department of Health and Social Care (DHSC), along with the incoming team.

He will officially take up the role as the new chief executive officer of NHS England on 1 April 2025, replacing Amanda Pritchard, who is stepping down at the end of this month.

Keep ReadingShow less
Community Pharmacies advised to reduce opening hours and services

Community Pharmacies advised to reduce opening hours and services

Breaking news: Pharmacies advised to reduce opening hours and services from April 1st

The government has been warned that community pharmacies will take collective action and reduce opening hours and services from April 1st unless there is an imminent clarity on a new funding contract.

The National Pharmacy Association (NPA) on Tuesday (17) announced that will advise its 6000 member pharmacies in England to take the unprecedented step in the face of what it has described as an April cliff-edge that will see a range of financial burdens placed on the sector.

Keep ReadingShow less
More patients on weight-loss injections undergoing gallbladder removal, warns pharmacist

Weight-loss injections can make bile more sludgy and even lead to the formation of gallstones

GettyImages

Weight-loss injections can cause gallstones, warns pharmacist

A leading pharmacist has raised concerns over a rise in gallbladder issues among individuals using weight-loss injections, particularly Eli Lilly’s Mounjaro (tirzepatide).

Deborah Grayson, a pharmacist and nutritional therapist, shared an alert in a TikTok video, highlighting the potential effects of weight-loss injections on gallbladder health.

Keep ReadingShow less